drugset / Trial / NCT04111926

Intraoperative Dexmedetomidine and Long-term Outcomes in Elderly After Major Surgery

NCT04111926 ↗

Phase 4 Completed 619 enrolled Peking University First Hospital
RandomizedParallel-groupQuadruple-blindPrevention

Summary

This is a 3-year follow-up of patients enrolled in a previous randomized controlled trial which showed that intraoperative dexmedetomidine reduced delirium in elderly patients after major non-cardiac surgery. The purpose of this study is to clarify the effects of intraoperative dexmedetomidine on long-term outcomes of these patients.

Timeline

Start
2019-10-07
Primary completion
2021-04-01
Completion
2021-04-01

Outcome

Missed primary endpoint

paper Overall survival did not differ between the two groups PMID 36736209 ↗

paper adjusted hazard ratio [HR] 0.78, 95% CI 0.53-1.13, P = 0.187 PMID 36736209 ↗

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 0.5 ug/kg —

Indications

No indication recorded.